Dr. Mofsen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3535 S Jefferson Ave
Suite 104
Saint Louis, MO 63118Phone+1 314-776-7999Fax+1 314-772-2257
Education & Training
Stony Brook Medicine/University HospitalResidency, Psychiatry, 1986 - 1989
Des Moines University College of Osteopathic MedicineClass of 1985
Certifications & Licensure
MO State License 1989 - 2026
MA State License 1994 - 2025
NY State License 1986 - 2020
AR State License 2016 - 2018
FL State License 1989 - 2018
Clinical Trials
- An Escalating Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LNK 754 in Elderly Volunteers and in Subjects With Mild Alzheimer's Disease Start of enrollment: 2009 Nov 01
- Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia Start of enrollment: 2011 Jul 01
- Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia Start of enrollment: 2011 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 17 citationsA randomized, double-blind, multiple-dose study of the pan-genotypic NS5A inhibitor samatasvir in patients infected with hepatitis C virus genotype 1, 2, 3 or 4Bradley D. Vince, J. Hill, Eric Lawitz, William O'Riordan, Lynn R. Webster
Journal of Hepatology. 2014-05-01
Committees
- Ethics Committee, Schizophrenia International Research Society 2018 - Present
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
